Xenetic Biosciences News

10-Q: Quarterly report

05:37

8-K: Current report

Nov 7 22:08

EFFECT: Others

Nov 4 19:05

8-K: Current report

Nov 1 05:01

ARS: Annual Report to Security Holders

Nov 1 04:56

DEFA14A: Others

Nov 1 04:45

DEF 14A: Definitive information statements

Nov 1 04:38

S-3: Registration statement for specified transactions by certain issuers

Oct 22 05:05

8-K: Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14 20:04

10-Q: Q2 2024 Earnings Report

Aug 14 04:37

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Jul 19 04:16

4: Statement of changes in beneficial ownership of securities-Officer PARSLOW JAMES F

Jun 22 05:02

8-K: Current report

Jun 22 04:38

8-K: Current report

May 23 05:05

8-K: Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 10 20:34

10-Q: Q1 2024 Earnings Report

May 10 05:06

10-K/A: Annual report (Amendment)

Apr 27 04:37

Xenetic Biosciences | 8-K: Current report

Mar 22 20:01

Xenetic Biosciences | 10-K: FY2023 Annual Report

Mar 22 05:07

Xenetic Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(14.0%),CLS Therapeutics Ltd.(9.6%), etc.

Mar 19 01:50